Lexaria Bioscience Corp. (LEXX)
1.14
+0.05
(+4.59%)
USD |
NASDAQ |
Dec 09, 13:20
Lexaria Bioscience EPS Diluted (Quarterly): -0.1378 for Aug. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Oncolytics Biotech, Inc. | -0.1032 |
| Aurinia Pharmaceuticals, Inc. | 0.232 |
| Edesa Biotech, Inc. | -0.2491 |
| Xenon Pharmaceuticals, Inc. | -1.147 |
| ProMIS Neurosciences, Inc. | -0.2371 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -2.697M |
| Revenue (Quarterly) | 0.174M |
| Total Expenses (Quarterly) | 2.870M |
| Enterprise Value | 21.98M |
| Gross Profit Margin (Quarterly) | 87.70% |
| Profit Margin (Quarterly) | -1.55K% |
| Earnings Yield | -58.07% |
| Normalized Earnings Yield | -57.29 |